Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in acute lymphoblastic leukemia

Activating mutations in NOTCH1 are common in T-cell acute lymphoblastic leukemia (TALL). Here we identify glutaminolysis as a critical pathway for leukemia cell growth downstream of NOTCH1 and a key determinant of clinical response to anti-NOTCH1 therapies. Mechanistically, inhibition of NOTCH1 sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Herranz, Daniel, Ambesi-Impiombato, Alberto, Sudderth, Jessica, Sánchez-Martín, Marta, Belver, Laura, Tosello, Valeria, Xu, Luyao, Wendorff, Agnieszka A., Castillo, Mireia, Haydu, J. Erika, Márquez, Javier, Matés, José M., Kung, Andrew L., Rayport, Stephen, Cordon-Cardo, Carlos, DeBerardinis, Ralph J., Ferrando, Adolfo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598309/
https://www.ncbi.nlm.nih.gov/pubmed/26390244
http://dx.doi.org/10.1038/nm.3955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598309/
https://www.ncbi.nlm.nih.gov/pubmed/26390244
http://dx.doi.org/10.1038/nm.3955

Ejemplares similares